Management of the solitary thyroid nodule.
By Meei Yeung, J. Serpell. The Oncologist, 2008
741 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Surgery
View Paper: https://www.semanticscholar.org/paper/af211c61f5511616e56f798b9ddfee56aad0d08b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Surgery
Citations in the corpus
- Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors (2013, background): “The high prevalence of thyroid nodules, affecting up to 30%–50% of the population in late adulthood [21], constitutes an enormous reservoir of potential cancer lesions to be investigated.”
- Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. (2006, background): “The prevalence of such nodules increases with age (5).”
- Long‐term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation (2007, neutral): “Positive for malignancy 173 (5) 156 152 (97) PC 1 cm, 138; PC\ 1 cm, 8; FC, 2; poorly diff, 1; anaplastic, 1; MTC, 2 Suspicious for papillary carcinoma 314 (9) 288 173 (60) PC 1 cm, 149; PC\ 1 cm, 22; poorly diff, 1; MTC, 1 Suspicious for follicular neoplasm 328 (9) 268 74 (28) PC 1 cm, 37; PC\ 1 cm”
- Molecular genetics and diagnosis of thyroid cancer (2011, background): “The inability to rule out cancer in these nodules leads to diagnostic lobectomy for most of these patients, although 60–90% of the surgically removed thyroid nodules are found to be benign”
- Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. (2009, neutral): “terval before definitive diagnosis (5, 13).”
- MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. (2008, background): “Palpable nodules are common in the adult population, with an estimated prevalence in the United States in the range of 4–7% or 10–18 million affected individuals (21, 22 ).”